207 related articles for article (PubMed ID: 28947981)
1. Lin28B facilitates the progression and metastasis of pancreatic ductal adenocarcinoma.
Wang Y; Li J; Guo S; Ouyang Y; Yin L; Liu S; Zhao Z; Yang J; Huang W; Qin H; Zhao X; Ni B; Wang H
Oncotarget; 2017 Sep; 8(36):60414-60428. PubMed ID: 28947981
[TBL] [Abstract][Full Text] [Related]
2. SIRT6 Suppresses Pancreatic Cancer through Control of Lin28b.
Kugel S; Sebastián C; Fitamant J; Ross KN; Saha SK; Jain E; Gladden A; Arora KS; Kato Y; Rivera MN; Ramaswamy S; Sadreyev RI; Goren A; Deshpande V; Bardeesy N; Mostoslavsky R
Cell; 2016 Jun; 165(6):1401-1415. PubMed ID: 27180906
[TBL] [Abstract][Full Text] [Related]
3. Nuclear death receptor TRAIL-R2 inhibits maturation of let-7 and promotes proliferation of pancreatic and other tumor cells.
Haselmann V; Kurz A; Bertsch U; Hübner S; Olempska-Müller M; Fritsch J; Häsler R; Pickl A; Fritsche H; Annewanter F; Engler C; Fleig B; Bernt A; Röder C; Schmidt H; Gelhaus C; Hauser C; Egberts JH; Heneweer C; Rohde AM; Böger C; Knippschild U; Röcken C; Adam D; Walczak H; Schütze S; Janssen O; Wulczyn FG; Wajant H; Kalthoff H; Trauzold A
Gastroenterology; 2014 Jan; 146(1):278-90. PubMed ID: 24120475
[TBL] [Abstract][Full Text] [Related]
4. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
5. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
[TBL] [Abstract][Full Text] [Related]
6. RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis.
Li X; Xiao Y; Fan S; Xiao M; Wang X; Chen X; Li C; Zong G; Zhou G; Wan C
Exp Mol Pathol; 2016 Oct; 101(2):176-186. PubMed ID: 27498047
[TBL] [Abstract][Full Text] [Related]
7. The microRNA-218 and ROBO-1 signaling axis correlates with the lymphatic metastasis of pancreatic cancer.
He H; Di Y; Liang M; Yang F; Yao L; Hao S; Li J; Jiang Y; Jin C; Fu D
Oncol Rep; 2013 Aug; 30(2):651-8. PubMed ID: 23733161
[TBL] [Abstract][Full Text] [Related]
8. The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS.
Zhao WG; Yu SN; Lu ZH; Ma YH; Gu YM; Chen J
Carcinogenesis; 2010 Oct; 31(10):1726-33. PubMed ID: 20675343
[TBL] [Abstract][Full Text] [Related]
9. High mobility group AT-hook 2 and c-MYC as potential prognostic factors in pancreatic ductal adenocarcinoma.
Li K; Yang J; Chen J; Shi Y; Zhang Z; Chen W
Oncol Lett; 2020 Feb; 19(2):1584-1592. PubMed ID: 31966084
[TBL] [Abstract][Full Text] [Related]
10. TRIM71 suppresses tumorigenesis via modulation of Lin28B-let-7-HMGA2 signaling.
Yin J; Kim TH; Park N; Shin D; Choi HI; Cho S; Park JB; Kim JH
Oncotarget; 2016 Nov; 7(48):79854-79868. PubMed ID: 27821801
[TBL] [Abstract][Full Text] [Related]
11. CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma.
Meng F; Li W; Li C; Gao Z; Guo K; Song S
Int J Oncol; 2015 Mar; 46(3):1109-20. PubMed ID: 25502147
[TBL] [Abstract][Full Text] [Related]
12. miR-186 and 326 predict the prognosis of pancreatic ductal adenocarcinoma and affect the proliferation and migration of cancer cells.
Zhang ZL; Bai ZH; Wang XB; Bai L; Miao F; Pei HH
PLoS One; 2015; 10(3):e0118814. PubMed ID: 25742499
[TBL] [Abstract][Full Text] [Related]
13. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.
Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z
Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic circulating tumor cell profiling identifies LIN28B as a metastasis driver and drug target.
Franses JW; Philipp J; Missios P; Bhan I; Liu A; Yashaswini C; Tai E; Zhu H; Ligorio M; Nicholson B; Tassoni EM; Desai N; Kulkarni AS; Szabolcs A; Hong TS; Liss AS; Fernandez-Del Castillo C; Ryan DP; Maheswaran S; Haber DA; Daley GQ; Ting DT
Nat Commun; 2020 Jul; 11(1):3303. PubMed ID: 32620742
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma.
Vaz AP; Deb S; Rachagani S; Dey P; Muniyan S; Lakshmanan I; Karmakar S; Smith L; Johansson S; Lele S; Ouellette M; Ponnusamy MP; Batra SK
Oncotarget; 2016 Jan; 7(3):3317-31. PubMed ID: 26689992
[TBL] [Abstract][Full Text] [Related]
16. DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
Sun J; Bi F; Yang Y; Zhang Y; Jin A; Li J; Lin Z
Oncol Rep; 2017 Feb; 37(2):857-864. PubMed ID: 27959420
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4.
Xia X; Zhang K; Cen G; Jiang T; Cao J; Huang K; Huang C; Zhao Q; Qiu Z
Oncotarget; 2015 Aug; 6(25):21046-63. PubMed ID: 26019136
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA profiling of pancreatic ductal adenocarcinoma (PDAC) reveals signature expression related to lymph node metastasis.
Lemberger M; Loewenstein S; Lubezky N; Nizri E; Pasmanik-Chor M; Barazovsky E; Klausner JM; Lahat G
Oncotarget; 2019 Apr; 10(27):2644-2656. PubMed ID: 31080555
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-183 is involved in cell proliferation, survival and poor prognosis in pancreatic ductal adenocarcinoma by regulating Bmi-1.
Zhou L; Zhang WG; Wang DS; Tao KS; Song WJ; Dou KF
Oncol Rep; 2014 Oct; 32(4):1734-40. PubMed ID: 25109303
[TBL] [Abstract][Full Text] [Related]
20. [Expression and clinical significance of Tspan 1 and Integrin α6 in human pancreatic ductal adenocarcinoma].
Shi G; Dong M; Sheng W; Zhou J; Yu D; Sun W
Zhonghua Wai Ke Za Zhi; 2014 Oct; 52(10):781-6. PubMed ID: 25573220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]